产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
CAS No. |
919936-70-2 |
|---|---|
中文名称 |
3-苯基-5-(((5-(吡啶-4-基)-1,3,4-恶二唑-2-基)硫基)甲基)-1,2,4-恶二唑 |
英文名称 |
3-Phenyl-5-(((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)methyl)-1,2,4-oxadiazole |
别名 |
4-(5-{[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]sulfanyl}-1,3,4-oxadiazol-2-yl)pyridine;Pyridine, 4-[5-[[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]thio]-1,3,4-oxadiazol-2-yl]-;GS87;4-[5-[[(3-Phenyl-1,2,4-oxadiazol-5-yl)methyl]thio]-1,3,4-oxadiazol-2-yl]pyridine;GS-87,GSK3α,GSK-3,Inhibitor,Glycogen synthase kinase 3,MAPK,GS 87,inhibit,Glycogen synthase kinase-3,GSK3,GS87,AML,differentiation,GSK3β;3-Phenyl-5-(((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)methyl)-1,2,4-oxadiazole;GS87, 10 mM in DMSO |
标准英文名 |
3-phenyl-5-(((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)methyl)-1,2,4-oxadiazole |
MDL No. |
MFCD09295617 |
分子式 |
C16H11N5O2S |
分子量 |
337.36 |
精确分子量 |
337.06 |
SMILES |
C1(C2=NN=C(SCC3=NC(C4=CC=CC=C4)=NO3)O2)=CC=NC=C1 |
标准SMILES |
C(SC1=NN=C(O1)C1C=CN=CC=1)C1=NC(=NO1)C1C=CC=CC=1 |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
HNTUWEZDVRVSFY-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|